| Name | Title | Contact Details |
|---|
The Medical University of South Carolina (MUSC) is a public institution of higher learning the purpose of which is to preserve and optimize human life in South Carolina and beyond. The university provides an interprofessional environment for learning and discovery through education of health care professionals and biomedical scientists, research in the health sciences and provision of comprehensive health care.
Entelos is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical DecisionPoint is a Montvale, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Saint Joseph Medical Center is a Polson, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.